Alison L. Hannah

基本信息

浏览量：183

职业迁徙

个人简介

Dr. Hannah has over 25 years' experience in the development of investigational cancer chemotherapies. Since 2000, she has served as a consultant to the pharmaceutical industry, working with over 20 companies with a focus on molecularly targeted therapy

研究兴趣

论文共 232 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Discovery of Novel Inhibitors of the Epigenetic Regulatory KAT6A Histone Acetyl Transferase and Their Anti-Tumor Activity in Breast Cancer Cells

Leslie Holsinger, Roopa Rai, Rahul R. Nagawade, Benoy Pal, Samir Pawar, Pankaj Singh, Krishna Putta,Mahaboobi Jaleel, Tove Bostrom,Jakob Karen, Qianyang Huang,Alison Hannah

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

609 A Phase 1 Clinical Trial of GEN2, a Personalizing Gene Vector Immunotherapy, in Combination with Valganciclovir in Adult Patients with Hepatocellular Carcinoma or Tumors Metastatic to Liver

Priscilla Caguioa, Maria Belen Tamayo, John P Querol, Necy S Juat,Li Liu, Allen Wang, Joe McNulty, Robert G Johnson,Alison L Hannah

Regular and Young Investigator Award Abstracts (2024)

引用0浏览0引用

Abstract PO3-26-04: Discovery of Novel Inhibitors of the Epigenetic Regulatory KAT6A Histone Acetyl Transferase and Their Anti-Tumor Activity in Breast Cancer Cells

Leslie Holsinger, Roopa RaI, Rahul R. Nagawade, Benoy Pal, Samir Pawar, Pankaj Singh, Krishna Putta,Mahaboobi Jaleel, Tove Bostrom,Jakob Karen, Qianyang Huang,Alison Hannah

Cancer Researchno. 9_Supplement (2024): PO3-26

引用0浏览0引用

Serial Assessment of GEN2, a Retroviral Vector for Gene Transfer of an Optimized Thymidine Kinase and GM-CSF, for Genomic Integration into Peripheral Blood Mononuclear Cells (pbmcs) in a Phase 1 Clinical Trial in Adult Patients with Solid Tumors